Cybersecurity & Engineering

Cybersecurity failures in MedTech have consequences beyond compliance. They threaten patient safety, device reliability, and commercial viability. Regulatory expectations continue to evolve, and generic cybersecurity consultancies rarely understand the nuances of FDA guidance, clinical workflows, or the constraints of medical hardware and embedded systems.

Avania’s cybersecurity model is tailored specifically to device development. We translate guidance into actionable requirements, link security decisions to device architecture, and support the full regulatory narrative from threat modeling through submission.

Why Medical Devices Need an FDA-First Cybersecurity Approach

Traditional cybersecurity firms focus on networks, not devices. They rarely understand FDA SBOM formats, MDR guidance, or clinical exceptions such as emergency access for implantables.

Avania’s heritage is medical devices. We understand embedded systems, wireless protocols, hardware constraints, and regulatory evidence requirements. When penetration testing identifies vulnerabilities, our engineering teams implement hardware- or firmware-level mitigations rather than relying solely on software patches. When EU MDR expectations must align with FDA security architecture views, we reconcile both to create a unified, defensible submission.

Most cybersecurity partners work within a single regulatory framework. Avania prepares cybersecurity documentation for FDA and EU authorities simultaneously.

Where requirements align, such as threat modeling, risk-based controls, secure development, testing, and post-market vigilance, we build unified programs. Where they diverge, including FDA’s emphasis on SBOM formats and coordinated disclosure compared with the EU’s state-of-the-art justification, we navigate those differences efficiently without duplicating effort.